STAA Q1 2019 Earnings — STAAR Surgical Company Revenue & Financial Results | Market Cap Arena

STAASTAAR Surgical Company

$871M

Q1 2019 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$33M+20.3% YoY

Gross Profit

$24M74.2% margin

Operating Income

$2M4.8% margin

Net Income

$1M4.2% margin

EPS (Diluted)

$0.03

QoQ Revenue Growth

+4.5%

Cash Flow

Operating Cash Flow

$731,000

Free Cash Flow

-$2M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$177M

Total Liabilities

$40M

Stockholders' Equity

$137M

Cash & Equivalents

$102M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$33M	$27M	+20.3%
Gross Profit	$24M	$19M	+24.4%
Operating Income	$2M	$799,000	+95.9%
Net Income	$1M	$583,000	+134.5%

Revenue Segments

Implantable Collamer Lenses

$28M85%

Intraocular Lenses

$4M12%

Other Surgical Products

$780,0002%

Geographic Segments

Other Countries

$12M37%

CHINA

$12M36%

JAPAN

$6M17%

KOREA, REPUBLIC OF

$3M10%